2 completed, 1 recruiting. 3 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 2, Recruiting 1 |
| Phase 2 | 1 | Completed 1 |
Follow Patient Navigation: new trials by email Literature Review of Patient Navigation trials Research Report on Patient Navigation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Reducing Missed Appointments Reminder message and patient navigation - Neurodevelopmental Disorders | Phase 3 | Recruiting | Hugo W. Moser Research Institute at Kennedy Krieger, Inc. | 5000 | 2025-12-29 | 2026-03-18 |
| Opioid Use Disorder Treatment Linkage at Strategic Touchpoints Using Buprenorphine Patient Navigation, Buprenorphine - Opioid-use Disorder | Phase 2 / Phase 3 | Completed | Friends Research Institute, Inc. | 373 | 2021-09-17 | 2026-05-29 |
| Injectable Pharmacotherapy for Opioid Use Disorders (IPOD) XR-NTX, XR-NTX+PN, ETAU - Opioid Use Disorders | Phase 3 | Completed | University of California, Los Angeles | 151 | 2015-06-01 | 2020-01-22 |
Opioid-Related Disorders (2) · Neurodevelopmental Disorders (1)
Friends Research Institute, Inc. (1) · Hugo W. Moser Research Institute at Kennedy Krieger, Inc. (1) · University of California, Los Angeles (1)
United States (3)
David Farabee, PhD (1) · Jan Gryczynski (1)
PMID 27282118, PMID 38456042, PMID 40342086
R01DA045724 (1)